EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer

Anna Di Matteo iD, Elisa Belloni, Davide Pradella iD, Anna Maria Chiaravalli iD, Giacomo Maria Pini, Mattia Bugatti, Roberta Alfieri iD, Chiara Barzan iD, Elena Franganillo Tena, Silvia Bione iD, Elisa Terenzani iD, Fausto Sessa und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Di Matteo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Alternative Splicing, Up-Regulation, Endothelial Cells, Stomach Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Associazione Italiana per la Ricerca sul Cancro, Fondazione Adriano Buzzati-Traverso.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is crucial for cancer progression. While several anti-angiogenic drugs are in use for cancer treatment, their clinical benefits are unsatisfactory. Thus, a deeper understanding of the mechanisms sustaining cancer vessel growth is fundamental to identify novel biomarkers and therapeutic targets. Alternative splicing (AS) is an essential modifier of human proteome diversity. Nevertheless, AS contribution to tumor vasculature development is poorly known. The Neuro-Oncological Ventral Antigen 2 (NOVA2) is a critical AS regulator of angiogenesis and vascular development. NOVA2 is upregulated in tumor endothelial cells (ECs) of different cancers, thus representing a potential driver of tumor blood vessel aberrancies. Here, we identified novel AS transcripts generated upon NOVA2 upregulation in ECs, suggesting a pervasive role of NOVA2 in vascular biology. In addition, we report that NOVA2 is also upregulated in ECs of gastric cancer (GC), and its expression correlates with poor overall survival of GC patients. Finally, we found that the AS of the Rap Guanine Nucleotide Exchange Factor 6 (RapGEF6), a newly identified NOVA2 target, is altered in GC patients and associated with NOVA2 expression, tumor angiogenesis, and poor patient outcome. Our findings provide a better understanding of GC biology and suggest that AS might be exploited to identify novel biomarkers and therapeutics for anti-angiogenic GC treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingUp-RegulationEndothelial CellsStomach NeoplasmsNeovascularization, PathologicHumansMaleFemaleAdultMiddle AgedAgedAged, 80 and overBiomarkersPrognosisCells, CulturedAnimalsMiceNeuro-Oncological Ventral AntigenGuanine Nucleotide Exchange Factors

Stichwörter der Autor:innen

RNA binding proteinsalternative splicingangiogenesiscancer biomarkersgastric cancertumor vasculature

Substanzen

BiomarkersNOVA2 protein, humanNeuro-Oncological Ventral AntigenRAPGEF6 protein, humanGuanine Nucleotide Exchange Factors

Autor:innen und Institutionen

  • Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy.
  • Department of Pathology, Ospedale di Circolo, ASST-Sette Laghi, 21100 Varese, Italy.
  • Department of Molecular and Translational Medicine, University of Brescia, 25100 Brescia, Italy.
  • Istituto Universitario di Studi Superiori (IUSS), Università degli Studi di Pavia, 27100 Pavia, Italy.
  • Dipartimento di Biologia e Biotecnologie "Lazzaro Spallanzani", Università degli Studi di Pavia, 27100 Pavia, Italy.
  • Department of Medicine and Surgery, Università degli Studi dell'Insubria, 21100 Varese, Italy.

ORCID-Profile: Anna Di Matteo, Davide Pradella, Anna Maria Chiaravalli, Roberta Alfieri, Chiara Barzan, Silvia Bione, Elisa Terenzani, Christopher D R Wyatt, William Vermi, Claudia Ghigna

Förderung

  • Italian Association for Cancer Research
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Adriano Buzzati-Traverso
  • AIRC fellowship for Italy
  • Fondazione Umberto Veronesi

Zitieren

APA

Di Matteo, A., Belloni, E., Pradella, D., Chiaravalli, A. M., Pini, G. M., Bugatti, M., Alfieri, R., Barzan, C., Franganillo Tena, E., Bione, S., Terenzani, E., Sessa, F., Wyatt, C. D. R., Vermi, W., & Ghigna, C. (2023). Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098102

Vancouver

Di Matteo A, Belloni E, Pradella D, Chiaravalli AM, Pini GM, Bugatti M, et al. Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098102

BibTeX
@article{DiMatteo2023,
  author = {Di Matteo, Anna and Belloni, Elisa and Pradella, Davide and Chiaravalli, Anna Maria and Pini, Giacomo Maria and Bugatti, Mattia and Alfieri, Roberta and Barzan, Chiara and Franganillo Tena, Elena and Bione, Silvia and Terenzani, Elisa and Sessa, Fausto and Wyatt, Christopher D R and Vermi, William and Ghigna, Claudia},
  title = {Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098102}
}
Kostenlos starten →